Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Shanghai International Convention Center

May 24, 2015 8:30 AM - May 27, 2015 5:00 PM

No. 2727, Riverside Avenue, Pudong, 200120 Shanghai, China

The 7th DIA China Annual Meeting

Session 0705 Detection and Evaluation of Immunogenicity of Biologics

Speaker(s)

Michael  Anderson

Recommendations from the AAPS LBABFG Biosimilars Action Program Committee on the Development and Validation of ADA assays for Biosimilars

Michael Anderson

Biologics Development Services, LLC, USA, China

President and Chief Scientific Officer

Eric  Liang

Eric Liang

Eric Liang

Novartis, China

Group Manager/CNIBR DMPK-Biologics

Dongbei  Li

Important Consideration in Anti-drug Antibody Assay Development

Dongbei Li

Wuxi AppTec, China

Senior Director, Bioanalytical services

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.